Markets-and-Money
MaxCyte Shares Slide as Investors Weigh $151.8 Million Akron Bio Acquisition
MaxCyte shares fell after its $151.8 million Akron Bio deal, as investors weighed dilution risk, cash use and broader biotech M&A skepticism.
November 10, 2026
Defense
Hegseth Impeachment Vote Puts Pentagon Leadership and Defense Spending in Focus
```json { "title": "Hegseth Impeachment Vote Puts Pentagon Leadership and Defense Spending in Focus", "summary": "A …
Nov 10
Markets-and-Money
Hot CPI Report Sends Yields Higher as Fed Rate-Hike Bets Shake Markets
A hotter October CPI report pushed Treasury yields higher, strengthened the US dollar and forced investors to reassess D…
Nov 10
Markets-and-Money
GFL Environmental Loses Buyout Premium After Board Rejects $52 Offer
GFL Environmental shares plunged after its board rejected a $52 offer and ended a strategic review, removing a near-term…
Nov 10
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Markets-and-Money
Hot October CPI Sends S&P 500 Futures Lower as December Fed Hike Bets Rise
Nov 10, 2026
Markets-and-Money
RBC’s Australian Asset-Management Deal Extends Its Global Wealth-Building Strategy
Nov 9, 2026
Markets-and-Money
Boeing Workforce Cuts Put Production Ramp and Delivery Outlook Under the Microscope
Nov 9, 2026
Markets-and-Money
Goodyear’s CEO Shake-Up Puts Turnaround Execution Under the Microscope
Nov 9, 2026